We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
Service Member Completion of Laboratory Follow-Up After Emergency Transfusion With Freshly Collected Blood Products.
Military Medicine 2016 September
BACKGROUND: Transfusion of freshly collected blood products (FCBP) is sometimes necessary to save service member (SM) lives in austere deployed environments. Recipients of FCBPs are administratively tracked and offered serial serologic testing via the Armed Services Blood Program "Blood Look Back" (BLB) program to assure early detection of post-transfusion infections.
OBJECTIVES: This study evaluates demographic and clinical features influencing SM completion of recommended BLB laboratory follow-up after transfusion with FCBPs.
METHODS: Using BLB programmatic data, a retrospective cohort study was performed examining U.S. SM transfusion recipients of FCBPs from June 1, 2006, through December 31, 2012. Multivariate logistic regression was used to examine clinical and demographic factors influencing completion of BLB recommended follow-up.
RESULTS: Of eligible subjects, 69% (n = 778) completed 12-month recommended BLB follow-up. As compared to other services, U.S. soldiers demonstrated greatest compliance with BLB recommendations with 71.7% completing recommended follow-up. As compared to the Army, SMs from the Air Force (odds ratio [OR] = 0.35, 95% confidence interval [CI] = 0.15-0.85), Marine Corps (OR = 0.51, 95% CI = 0.37-0.71), and Navy (OR = 0.29, 95% CI = 0.11-0.74) were less likely to complete recommended follow-up; however, differences in follow-up among the services attenuated over time. Neither the type of FCBP (platelets versus whole blood) nor the volume of FCBP transfused significantly altered SM likelihood of competing recommended follow-up.
CONCLUSIONS: More than 2 out of 3 SMs completed recommended 12-month BLB follow-up after transfusion with FCBPs with greater compliance in Army SMs compared to other services. Programmatic changes implemented by the BLB program were temporally associated with increased SM compliance with recommended follow-up as well as reduction of disparities in follow-up observed between the services.
OBJECTIVES: This study evaluates demographic and clinical features influencing SM completion of recommended BLB laboratory follow-up after transfusion with FCBPs.
METHODS: Using BLB programmatic data, a retrospective cohort study was performed examining U.S. SM transfusion recipients of FCBPs from June 1, 2006, through December 31, 2012. Multivariate logistic regression was used to examine clinical and demographic factors influencing completion of BLB recommended follow-up.
RESULTS: Of eligible subjects, 69% (n = 778) completed 12-month recommended BLB follow-up. As compared to other services, U.S. soldiers demonstrated greatest compliance with BLB recommendations with 71.7% completing recommended follow-up. As compared to the Army, SMs from the Air Force (odds ratio [OR] = 0.35, 95% confidence interval [CI] = 0.15-0.85), Marine Corps (OR = 0.51, 95% CI = 0.37-0.71), and Navy (OR = 0.29, 95% CI = 0.11-0.74) were less likely to complete recommended follow-up; however, differences in follow-up among the services attenuated over time. Neither the type of FCBP (platelets versus whole blood) nor the volume of FCBP transfused significantly altered SM likelihood of competing recommended follow-up.
CONCLUSIONS: More than 2 out of 3 SMs completed recommended 12-month BLB follow-up after transfusion with FCBPs with greater compliance in Army SMs compared to other services. Programmatic changes implemented by the BLB program were temporally associated with increased SM compliance with recommended follow-up as well as reduction of disparities in follow-up observed between the services.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app